Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
4.010
+0.050 (1.26%)
At close: Nov 13, 2026, 4:00 PM EST
3.994
-0.016 (-0.41%)
After-hours: Nov 13, 2026, 5:06 PM EST
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $198.22 million as of November 13, 2026. It is the 20,624th most valuable company in the world and the 3,544th biggest in the United States. Its market cap has increased by 102.91% in one year.
Market Cap
198.22M
Enterprise Value
-111.71M
1-Year Change
102.91%
Global Rank
Country Rank
#3,544 United States
Category
ChartMarket Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has increased from $176.76M to $198.22M, an increase of 12.14%. That is a compound annual growth rate of 5.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 198.22M | 88.25% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Korro Bio | 215.90M |
| Fate Therapeutics | 212.08M |
| Cartesian Therapeutics | 210.17M |
| MediWound | 201.64M |
| Sol-Gel Technologies | 201.35M |
| Compugen | 197.97M |
| Palisade Bio | 196.93M |
| Pyxis Oncology | 194.71M |